← FDA DRUG APPROVALS

FDA ANDA · ANDA080281

ORETON

Sponsor: SCHERING

APPLICATION
ANDA080281
TYPE
ANDA
ORIGINAL APPROVAL
1979-08-03
LATEST ACTION
1994-01-19
ROUTE
BUCCAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ORETONDiscontinued
METHYLTESTOSTERONE 10MG · TABLET · BUCCAL

Approval history

1994-01-19Labeling · Supplement 9AP
1991-06-27Labeling · Supplement 7AP
1991-06-27Labeling · Supplement 8AP
1979-08-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →